COMMUNIQUE No. 19

July 2017

The OTC directors met via teleconference on Monday, 24 July 2017. The following items formed part of the agenda:

Website

There will be on-going maintenance of the website to ensure currency of information and simplicity of navigation.

Program Accreditation Committee (PAC)

  • Five site visitsare scheduled for the remainder of 2017.
  • Assessor training will be conducted in the near future.
  • One accreditation recommendation has been submitted to, and approved by the OTBA in the period since the previous OTC meeting.
  • One accreditation recommended is pending approval by the OTBA.
  • OTC will be represented at a forum for education providers in South Australia, organised by OTBA.

Overseas Qualification Assessment Committee (OQAC)

  • Processes continue to be reviewed to ensure overseas-trained practitioners are able to navigate the Stage 2 period of supervised practice easily.
  • Feedback from supervisors regarding the period of supervised practice has been positive.

Governance and Strategic Affairs Committee (GSAC)

Proposed strategic planning will be scheduled in the next 12 months.

Risk management will be reviewed on a regular basis.

Health Professions Accreditation CollaborativeForum(HPACF)

The Forummeeting held in Canberra on 12 May 2017 was attended by Ms Jan Erven.

Assoc Prof Adamson and Mr Bradbury attended the Forum meeting in Melbourne on 14 July 2017.

Accreditation Standards

The review of the accreditation standards is progressing as scheduled with an estimated completion date of mid-2018. The process will map out stakeholder engagement, following the OTBA guidelines. The steering committee and reference group have met on one occasion since the last meeting of the directors at the end of April 2017. Consultations will be sought from internal and external stakeholders.

National Registration and Accreditation Scheme activities

It was noted 106 submissions had been received by the NRAS Review team. The submission made by OTC is available on the Council website: OTC submission to NRAS Review 2017

***

OTC Communique 11August 2015Page 1 of 1